2009- Signature of a total agency contract for Japan market with Japanese’s Nosan Corporation in the medical product absorption field - July: Receipt of £680 000 of financial support from Paris Ile de France and Seine-Saint-Denis department - Oroxcell’s project concerning the pain program has been accreditated by the Biocluster Medicen Paris Region and financed by the French Ministry of Industry - November, 4th to 5th: ESAC, which is the scientific committee of ECVAM, reports that the results obtained in the studies made by L’Oréal, Lancaster Cotty and Oroxcell, concerning the RHE® validation by SkinEthic, is able to completely substitute the Draize test in irritation evaluation of chemicals on the skin - March, 9th to 10th: Oroxcell has presented a poster, VALIDATION OF THE RECONSTRUCTED HUMAN EPIDERMIS (RHE) SKIN IRRITATION ASSAY FOR FULL REPLACEMENT OF THE DRAIZE TEST 1 | 2 |
